News | August 09, 2011

Caliper, Carestream Settle Lawsuits

August 9, 2011 ­– Caliper Life Sciences Inc. announced it favorably settled two patent lawsuits with Carestream Health Inc.

Carestream filed one of the lawsuits in July 2010, alleging infringement of a patent covering multimodal in vivo imaging. The suit, filed in the U.S. District Court for the Western District of Wisconsin, Madison Division, Carestream alleged Caliper’s IVIS Lumina XR system infringes on Carestream Health’s U.S. patent relating to an imaging system where one or more immobilized small animals can be imaged in several imaging modes without moving the animal.

In the second lawsuit, filed in February 2010, Caliper, its wholly owned subsidiary, Xenogen, and Stanford University alleged that Carestream's marketing and sales of its instrument systems induced infringement of seven imaging patents that are exclusively licensed to Xenogen by Stanford University.

To settle these lawsuits, Carestream and Caliper have agreed to dismiss their respective claims and counterclaims. Carestream will not market and sell in-vivo optical imaging systems for certain applications covered by patents licensed from Stanford by Xenogen and Caliper. Carestream also agreed not to assert that the Lumina XR system as currently configured and sold by Caliper infringes any of Carestream's patents.

Caliper was represented by Mark Fox Evens and Eldora Ellison, Ph.D.,  of the law firm Sterne, Kessler, Goldstein & Fox, PLLC.

For more information: www.caliperLS.com

Related Content

Advanced imaging data exchange is now live in Colorado due to the partnership of Health Images and the Colorado Regional Health Information Organization

Getty Images

News | Radiology Business | May 18, 2020
May 18, 2020 — 
World’s largest deployment of a radiology-based AI diagnostic solution for COVID-19 using AI-based chest X-ray technology
News | Coronavirus (COVID-19) | May 18, 2020
May 18, 2020 — Behold.ai announced its partnership with Ap...
Chest radiograph of a 23-year-old male with no past medical history who tested positive for COVID-19 via RT-PCR and was subsequently discharged from the emergency department with home care and isolation precautions. Portable CXR shows right and left peripheral lower lung zone hazy opacities; total score=2

Top image: Chest radiograph of a 23-year-old male with no past medical history who tested positive for COVID-19 via RT-PCR and was subsequently discharged from the emergency department with home care and isolation precautions. Portable CXR shows right and left peripheral lower lung zone hazy opacities; total score=2.

Bottom image: Chest radiograph in a 32-year-old overweight (BMI=30) COVID-19 positive male with a history of childhood asthma who was subsequently admitted and intubated in the ICU for 3 days. Portable CXR shows opacities in all three right lung zones and in the left middle and lower lung zones; total score=5. Image courtesy of Mount Sinai Health System

News | Coronavirus (COVID-19) | May 15, 2020
May 15, 2020 — Chest X-rays performed on young and
Zegami, the Oxford University data visualization spin-out, has announced it has written to the health ministers of ten countries asking them to provide X-rays of COVID-19 infected lungs.
News | Coronavirus (COVID-19) | April 27, 2020
April 27, 2020 — Zegami, the Oxford University data visualization s
In response to the need for critical care during the COVID-19 crisis, Carestream Health has increased production of its portable diagnostic imaging systems. As unlikely facilities begin to function as urgent care units, Carestream’s DRX-Revolution Mobile X-ray System and DRX-Revolution Nano Mobile X-ray System bring the X-ray exam to the patient’s bedside, delivering high-quality digital radiography images to healthcare providers in real time to aid in patient diagnosis—whenever and wherever needed
News | Coronavirus (COVID-19) | April 27, 2020
April 27, 2020 — In response to the need for critical care during the...
Two-dimensional (2D) Ruddlesden-Popper phase layered perovskites (BA)2(MA)2Pb3I10 with three layers of inorganic octahedral slab and bulky organics as spacers

Two-dimensional (2D) Ruddlesden-Popper phase layered perovskites (BA)2(MA)2Pb3I10 with three layers of inorganic octahedral slab and bulky organics as spacers. Image courtesy of Dave Tsai/Los Alamos

News | X-Ray | April 24, 2020
April 24, 2020 — Getting an X-ray at the dentist or
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

News | Coronavirus (COVID-19) | April 24, 2020
April 24, 2020 — The Food and Drug Administration (FDA or the Agency) plays a critic
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty images

News | X-Ray | April 14, 2020
April 14, 2020 — Chest X-rays are often used to detect infections in the lungs, but the world’s largest study of its
X-ray detectors made with 2-dimensional perovskite thin films convert X-ray photons to electrical signals without requiring an outside power source, and are a hundred times more sensitive than conventional detectors. Image courtesy of Los Alamos National Laboratory

X-ray detectors made with 2-dimensional perovskite thin films convert X-ray photons to electrical signals without requiring an outside power source, and are a hundred times more sensitive than conventional detectors. Image courtesy of Los Alamos National Laboratory

News | X-Ray | April 13, 2020
April 13, 2020 — A new X-ray detector prototype is